메뉴 건너뛰기




Volumn 34, Issue , 2016, Pages 30-36

Reduced non-switched memory B cell subsets cause imbalance in B cell repertoire in systemic sclerosis

Author keywords

Autoimmunity; CD95+ B cells; Memory B cells; Multiparametric flow cytometry; Systemic sclerosis

Indexed keywords

B7 ANTIGEN; CD19 ANTIGEN; CD27 ANTIGEN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; FAS ANTIGEN; IMMUNOGLOBULIN D; BIOLOGICAL MARKER; CD19 MOLECULE, HUMAN; FAS PROTEIN, HUMAN;

EID: 84994408907     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (36)

References (50)
  • 1
    • 0346727461 scopus 로고    scopus 로고
    • Following the molecular pathways toward an understanding of the pathogenesis of systemic sclerosis
    • JIMENEZ SA, DERK CT: Following the molecular pathways toward an understanding of the pathogenesis of systemic sclerosis. Ann Intern Med 2004; 140: 37-50.
    • (2004) Ann Intern Med , vol.140 , pp. 37-50
    • Jimenez, S.A.1    Derk, C.T.2
  • 2
    • 33745277147 scopus 로고    scopus 로고
    • Stimulatory autoantibodies to the PDGF receptor in systemic sclerosis
    • BARONI SS, SANTILLO M, BEVILACQUA F et al.: Stimulatory autoantibodies to the PDGF receptor in systemic sclerosis. N Engl J Med 2006; 354: 2667-76.
    • (2006) N Engl J Med , vol.354 , pp. 2667-2676
    • Baroni, S.S.1    Santillo, M.2    Bevilacqua, F.3
  • 3
    • 0142059804 scopus 로고    scopus 로고
    • Systemic and cell type-specific gene expression patterns in scleroderma skin
    • WHITFIELD ML, FINLAY DR, MURRAY JI et al.: Systemic and cell type-specific gene expression patterns in scleroderma skin. Proc Natl Acad Sci USA 2003; 100: 12319-24.
    • (2003) Proc Natl Acad Sci USA , vol.100 , pp. 12319-12324
    • Whitfield, M.L.1    Finlay, D.R.2    Murray, J.I.3
  • 4
    • 41149106388 scopus 로고    scopus 로고
    • The mosaic of autoimmunity: Prediction, autoantibodies, and therapy in autoimmune diseases-2008
    • SHOENFELD Y, BLANK M, ABU-SHAKRA M et al.: The mosaic of autoimmunity: Prediction, autoantibodies, and therapy in autoimmune diseases-2008. Isr Med Assoc J 2008; 10: 13-9.
    • (2008) Isr Med Assoc J , vol.10 , pp. 13-19
    • Shoenfeld, Y.1    Blank, M.2    Abu-Shakra, M.3
  • 5
    • 2642511623 scopus 로고    scopus 로고
    • Altered blood B lymphocyte homeostasis in systemic sclerosis: Expanded naive B cells and diminished but activated memory B cells
    • SATO S, FUJIMOTO M, HASEGAWA M, TAKEHARA K: Altered blood B lymphocyte homeostasis in systemic sclerosis: Expanded naive B cells and diminished but activated memory B cells. Arthritis Rheum 2004; 50: 1918-27.
    • (2004) Arthritis Rheum , vol.50 , pp. 1918-1927
    • Sato, S.1    Fujimoto, M.2    Hasegawa, M.3    Takehara, K.4
  • 6
    • 0024958107 scopus 로고
    • Polyclonal B lymphocyte activation in progressive systemic sclerosis
    • FAMULARO G, GIACOMELLI R, ALESSE E et al.: Polyclonal B lymphocyte activation in progressive systemic sclerosis. J Clin Lab Immunol 1989; 29: 59-63.
    • (1989) J Clin Lab Immunol , vol.29 , pp. 59-63
    • Famularo, G.1    Giacomelli, R.2    Alesse, E.3
  • 8
    • 75749103768 scopus 로고    scopus 로고
    • Anti-endothelial cell antibodies in systemic sclerosis
    • MIHAI C, TERVAERT JWC: Anti-endothelial cell antibodies in systemic sclerosis. Ann Rheum Dis 2010; 69: 319-24.
    • (2010) Ann Rheum Dis , vol.69 , pp. 319-324
    • Mihai, C.1    Tervaert, J.W.C.2
  • 9
    • 84873647366 scopus 로고    scopus 로고
    • Pulmonary arterial hypertension: New insights into the optimal role of current and emerging prostacyclin therapies
    • WAXMAN AB, ZAMANIAN RT: Pulmonary arterial hypertension: New insights into the optimal role of current and emerging prostacyclin therapies. Am J Cardiol 2013; 111 (5 Suppl.): 1A-16A.
    • (2013) Am J Cardiol , vol.111 , Issue.5 , pp. 1A-16A
    • Waxman, A.B.1    Zamanian, R.T.2
  • 10
    • 84921348464 scopus 로고    scopus 로고
    • Vascular Receptor Autoantibodies in Pulmonary Arterial Hypertension Associated with Systemic Sclerosis
    • BECKER MO, KILL A, KUTSCHE M et al.: Vascular Receptor Autoantibodies in Pulmonary Arterial Hypertension Associated with Systemic Sclerosis. Am J Respir Crit Care Med 2014; 190: 808-17. Available from: http://www.atsjournals.org/doi/abs/10.1164/rccm.201403-0442OC
    • (2014) Am J Respir Crit Care Med , vol.190 , pp. 808-817
    • Becker, M.O.1    Kill, A.2    Kutsche, M.3
  • 11
    • 0034544489 scopus 로고    scopus 로고
    • Quantitative genetic variation in CD19 expression correlates with autoimmunity
    • SATO S, HASEGAWA M, FUJIMOTO M, TEDDER TF, TAKEHARA K: Quantitative genetic variation in CD19 expression correlates with autoimmunity. J Immunol 2000; 165: 6635-43.
    • (2000) J Immunol , vol.165 , pp. 6635-6643
    • Sato, S.1    Hasegawa, M.2    Fujimoto, M.3    Tedder, T.F.4    Takehara, K.5
  • 12
    • 20644457110 scopus 로고    scopus 로고
    • Pathogenesis of systemic sclerosis: altered B cell function is the key linking systemic autoimmunity and tissue fibrosis
    • HASEGAWA M, FUJIMOTO M, TAKEHARA K, SATO S: Pathogenesis of systemic sclerosis: altered B cell function is the key linking systemic autoimmunity and tissue fibrosis. J Dermatol Sci 2005; 39: 1-7.
    • (2005) J Dermatol Sci , vol.39 , pp. 1-7
    • Hasegawa, M.1    Fujimoto, M.2    Takehara, K.3    Sato, S.4
  • 13
    • 75649124525 scopus 로고    scopus 로고
    • B lymphocytes: Shedding new light on the pathogenesis of systemic sclerosis
    • HASEGAWA M: B lymphocytes: Shedding new light on the pathogenesis of systemic sclerosis. J Dermatol 2010; 37: 3-10.
    • (2010) J Dermatol , vol.37 , pp. 3-10
    • Hasegawa, M.1
  • 14
    • 0021154318 scopus 로고
    • Lymphocytes in the skin of patients with progressive systemic sclerosis. Quantification, subtyping, and clinical correlations
    • ROUMM AD, WHITESIDE TL, MEDSGER TA, RODNAN GP: Lymphocytes in the skin of patients with progressive systemic sclerosis. Quantification, subtyping, and clinical correlations. Arthritis Rheum 1984; 27: 645-53.
    • (1984) Arthritis Rheum , vol.27 , pp. 645-653
    • Roumm, A.D.1    Whiteside, T.L.2    Medsger, T.A.3    Rodnan, G.P.4
  • 15
    • 84900030650 scopus 로고    scopus 로고
    • Association of immunological cell profiles with specific clinical phenotypes of scleroderma disease
    • LóPEZ-CACHO JM, GALLARDO S, POSADA M et al.: Association of immunological cell profiles with specific clinical phenotypes of scleroderma disease. Biomed Res Int 2014; 2014: 148293.
    • (2014) Biomed Res Int , vol.2014
    • López-Cacho, J.M.1    Gallardo, S.2    Posada, M.3
  • 16
    • 84922280087 scopus 로고    scopus 로고
    • Abnormal B lymphocyte activation and function in systemic sclerosis
    • YOSHIZAKI A, SATO S: Abnormal B lymphocyte activation and function in systemic sclerosis. Ann Dermatol 2015; 27: 1-9.
    • (2015) Ann Dermatol , vol.27 , pp. 1-9
    • Yoshizaki, A.1    Sato, S.2
  • 17
    • 85027911427 scopus 로고    scopus 로고
    • Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group
    • JORDAN S, DISTLER JHW, MAURER B et al.: Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group. Ann Rheum Dis (Internet). 2014;1-7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24442885
    • (2014) Ann Rheum Dis , pp. 1-7
    • Jordan, S.1    Distler, J.H.W.2    Maurer, B.3
  • 18
    • 59649109772 scopus 로고    scopus 로고
    • B cell depletion with rituximab in patients with diffuse cutaneous systemic sclerosis
    • LAFYATIS R, KISSIN E, YORK M et al.: B cell depletion with rituximab in patients with diffuse cutaneous systemic sclerosis. Arthritis Rheum 2009; 60: 578-83.
    • (2009) Arthritis Rheum , vol.60 , pp. 578-583
    • Lafyatis, R.1    Kissin, E.2    York, M.3
  • 19
    • 84863300540 scopus 로고    scopus 로고
    • Successful treatment of steroid and cyclophosphamide-resistant diffuse scleroderma-associated interstitial lung disease with rituximab
    • YOO WH: Successful treatment of steroid and cyclophosphamide-resistant diffuse scleroderma-associated interstitial lung disease with rituximab. Rheumatol Int 2012; 32: 795-8.
    • (2012) Rheumatol Int , vol.32 , pp. 795-798
    • Yoo, W.H.1
  • 20
    • 84926341813 scopus 로고    scopus 로고
    • Long-term efficacy of B cell depletion therapy on lung and skin involvement in diffuse systemic sclerosis
    • BOSELLO SL, DE LUCA G, RUCCO M et al.: Long-term efficacy of B cell depletion therapy on lung and skin involvement in diffuse systemic sclerosis. Semin Arthritis Rheum 2015; 44: 428-36.
    • (2015) Semin Arthritis Rheum , vol.44 , pp. 428-436
    • Bosello, S.L.1    De Luca, G.2    Rucco, M.3
  • 21
    • 33748788266 scopus 로고    scopus 로고
    • B-lymphocyte depletion reduces skin fibrosis and autoimmunity in the tight-skin mouse model for systemic sclerosis
    • HASEGAWA M, HAMAGUCHI Y, YANABA K et al.: B-lymphocyte depletion reduces skin fibrosis and autoimmunity in the tight-skin mouse model for systemic sclerosis. Am J Pathol 2006; 169: 954-66.
    • (2006) Am J Pathol , vol.169 , pp. 954-966
    • Hasegawa, M.1    Hamaguchi, Y.2    Yanaba, K.3
  • 22
    • 77950443096 scopus 로고    scopus 로고
    • Experience with rituximab in scleroderma: Results from a 1-year, proof-of-principle study
    • DAOUSSIS D, LIOSSIS SNC, TSAMANDAS AC et al.: Experience with rituximab in scleroderma: Results from a 1-year, proof-of-principle study. Rheumatology 2010; 49: 271-80.
    • (2010) Rheumatology , vol.49 , pp. 271-280
    • Daoussis, D.1    Liossis, S.N.C.2    Tsamandas, A.C.3
  • 23
    • 16544364829 scopus 로고    scopus 로고
    • The CD19-CD21 signal transduction complex of B lymphocytes regulates the balance between health and autoimmune disease: systemic sclerosis as a model system
    • TEDDER TF, POE JC, FUJIMOTO M, HAAS KM, SATO S: The CD19-CD21 signal transduction complex of B lymphocytes regulates the balance between health and autoimmune disease: systemic sclerosis as a model system. Curr Dir Autoimmun 2005; 8: 55-90.
    • (2005) Curr Dir Autoimmun , vol.8 , pp. 55-90
    • Tedder, T.F.1    Poe, J.C.2    Fujimoto, M.3    Haas, K.M.4    Sato, S.5
  • 25
    • 0034669990 scopus 로고    scopus 로고
    • Disturbed peripheral B lymphocyte homeostasis in systemic lupus erythematosus
    • ODENDAHL M, JACOBI A, HANSEN A et al.: Disturbed peripheral B lymphocyte homeostasis in systemic lupus erythematosus. J Immunol 2000; 165: 5970-9.
    • (2000) J Immunol , vol.165 , pp. 5970-5979
    • Odendahl, M.1    Jacobi, A.2    Hansen, A.3
  • 26
    • 84870980098 scopus 로고    scopus 로고
    • IgM+IgD+CD27+ B cells are markedly reduced in IRAK-4-, MyD88-, and TIRAPbut not UNC-93B-deficient patients
    • WELLER S, BONNET M, DELAGREVERIE H et al.: IgM+IgD+CD27+ B cells are markedly reduced in IRAK-4-, MyD88-, and TIRAPbut not UNC-93B-deficient patients. Blood 2012; 120: 4992-5001.
    • (2012) Blood , vol.120 , pp. 4992-5001
    • Weller, S.1    Bonnet, M.2    Delagreverie, H.3
  • 27
    • 0036676086 scopus 로고    scopus 로고
    • Diminished peripheral blood memory B cells and accumulation of memory B cells in the salivary glands of patients with Sjögren's syndrome
    • HANSEN A, ODENDAHL M, REITER K et al.: Diminished peripheral blood memory B cells and accumulation of memory B cells in the salivary glands of patients with Sjögren's syndrome. Arthritis Rheum 2002; 46: 2160-71.
    • (2002) Arthritis Rheum , vol.46 , pp. 2160-2171
    • Hansen, A.1    Odendahl, M.2    Reiter, K.3
  • 28
    • 0032528846 scopus 로고    scopus 로고
    • Absence of IgD-CD27+ memory B cell population in X-linked hyper-IgM syndrome
    • AGEMATSU K, NAGUMO H, SHINOZAKI K et al.: Absence of IgD-CD27+ memory B cell population in X-linked hyper-IgM syndrome. J Clin Invest 1998; 102: 853-60.
    • (1998) J Clin Invest , vol.102 , pp. 853-860
    • Agematsu, K.1    Nagumo, H.2    Shinozaki, K.3
  • 29
    • 0036493366 scopus 로고    scopus 로고
    • Severe deficiency of switched memory B cells (CD27(+)IgM(-)IgD(-)) in subgroups of patients with common variable immunodeficiency: a new approach to classify a heterogeneous disease
    • WARNATZ K, DENZ A, DRA R et al.: Severe deficiency of switched memory B cells (CD27(+)IgM(-)IgD(-)) in subgroups of patients with common variable immunodeficiency: a new approach to classify a heterogeneous disease. Blood 2002; 99: 1544-52.
    • (2002) Blood , vol.99 , pp. 1544-1552
    • Warnatz, K.1    Denz, A.2    Dra, R.3
  • 30
    • 39649097890 scopus 로고    scopus 로고
    • Cutting edge: anti-tumor necrosis factor therapy in rheumatoid arthritis inhibits memory B lymphocytes via effects on lymphoid germinal centers and follicular dendritic cell networks
    • ANOLIK JH, RAVIKUMAR R, BARNARD J et al.: Cutting edge: anti-tumor necrosis factor therapy in rheumatoid arthritis inhibits memory B lymphocytes via effects on lymphoid germinal centers and follicular dendritic cell networks. J Immunol 2008; 180: 688-92.
    • (2008) J Immunol , vol.180 , pp. 688-692
    • Anolik, J.H.1    Ravikumar, R.2    Barnard, J.3
  • 31
    • 84907385240 scopus 로고    scopus 로고
    • Primary Sjögren's Syndrome is characterized by distinct phenotypic and transcriptional profiles of IgD+ unswitched memory cells
    • ROBERTS MEP, KAMINSKI D, JENKS SA et al.: Primary Sjögren's Syndrome is characterized by distinct phenotypic and transcriptional profiles of IgD+ unswitched memory cells. Arthritis Rheumatol 2014; 66: 2558-69.
    • (2014) Arthritis Rheumatol , vol.66 , pp. 2558-2569
    • Roberts, M.E.P.1    Kaminski, D.2    Jenks, S.A.3
  • 32
    • 34248140178 scopus 로고    scopus 로고
    • A new population of cells lacking expression of CD27 represents a notable component of the B cell memory compartment in systemic lupus erythematosus
    • WEI C, ANOLIK J, CAPPIONE A et al.: A new population of cells lacking expression of CD27 represents a notable component of the B cell memory compartment in systemic lupus erythematosus. J Immunol 2007; 178: 6624-33.
    • (2007) J Immunol , vol.178 , pp. 6624-6633
    • Wei, C.1    Anolik, J.2    Cappione, A.3
  • 33
    • 45349091226 scopus 로고    scopus 로고
    • Activated memory B cell subsets correlate with disease activity in systemic lupus erythematosus: Delineation by expression of CD27, IgD, and CD95
    • JACOBI AM, REITER K, MacKAY M et al.: Activated memory B cell subsets correlate with disease activity in systemic lupus erythematosus: Delineation by expression of CD27, IgD, and CD95. Arthritis Rheum 2008; 58: 1762-73.
    • (2008) Arthritis Rheum , vol.58 , pp. 1762-1773
    • Jacobi, A.M.1    Reiter, K.2    Mackay, M.3
  • 34
    • 84878571051 scopus 로고    scopus 로고
    • Derailed B cell homeostasis in patients with mixed connective tissue disease
    • HAJAS A, BARATH S, SZODORAY P et al.: Derailed B cell homeostasis in patients with mixed connective tissue disease. Hum Immunol 2013; 74: 833-41.
    • (2013) Hum Immunol , vol.74 , pp. 833-841
    • Hajas, A.1    Barath, S.2    Szodoray, P.3
  • 35
    • 84866171442 scopus 로고    scopus 로고
    • The Relationship between CD27 Negative and Positive B Cell Populations in Human Peripheral Blood
    • WU Y-CB, KIPLING D, DUNN-WALTERS DK: The Relationship between CD27 Negative and Positive B Cell Populations in Human Peripheral Blood. Front Immunol 2011; 2: 81.
    • (2011) Front Immunol , vol.2 , pp. 81
    • Wu, Y.-C.B.1    Kipling, D.2    Dunn-Walters, D.K.3
  • 36
    • 0023854176 scopus 로고
    • Scleroderma (systemic sclerosis): Classification, subsets and pathogenesis
    • LEROY CE, BLACK C, FLEISCHMAJER R et al.: Scleroderma (systemic sclerosis): Classification, subsets and pathogenesis. J Rheumatol 1988; 15: 202-5.
    • (1988) J Rheumatol , vol.15 , pp. 202-205
    • Leroy, C.E.1    Black, C.2    Fleischmajer, R.3
  • 37
    • 84886777196 scopus 로고    scopus 로고
    • 2013 classification criteria for systemic sclerosis: An american college of rheumatology/European league against rheumatism collaborative initiative
    • Van Den HOOGEN F, KHANNA D, FRANSEN J et al.: 2013 classification criteria for systemic sclerosis: An american college of rheumatology/European league against rheumatism collaborative initiative. Arthritis Rheum 2013; 65: 2737-47.
    • (2013) Arthritis Rheum , vol.65 , pp. 2737-2747
    • Van Den Hoogen, F.1    Khanna, D.2    Fransen, J.3
  • 38
    • 77953484773 scopus 로고    scopus 로고
    • Construct validity evaluation of the European Scleroderma Study Group activity index, and investigation of possible new disease activity markers in systemic sclerosis
    • MINIER T, NAGY Z, BáLINT Z et al.: Construct validity evaluation of the European Scleroderma Study Group activity index, and investigation of possible new disease activity markers in systemic sclerosis. Rheumatology (Oxford) 2010; 49: 1133-45.
    • (2010) Rheumatology (Oxford) , vol.49 , pp. 1133-1145
    • Minier, T.1    Nagy, Z.2    Bálint, Z.3
  • 39
    • 37749017657 scopus 로고    scopus 로고
    • Survival and causes of death in 366 Hungarian patients with systemic sclerosis
    • CZIRJáK L, KUMáNOVICS G, VARJú C et al.: Survival and causes of death in 366 Hungarian patients with systemic sclerosis. Ann Rheum Dis 2008; 67: 59-63.
    • (2008) Ann Rheum Dis , vol.67 , pp. 59-63
    • Czirják, L.1    Kumánovics, G.2    Varjú, C.3
  • 40
    • 0042386341 scopus 로고    scopus 로고
    • European Scleroderma Study Group to define disease activity criteria for systemic sclerosis. IV. Assessment of skin thickening by modified Rodnan skin score
    • VALENTINI G, D'ANGELO S, DELLA ROSSA A, BENCIVELLI W, BOMBARDIERI S: European Scleroderma Study Group to define disease activity criteria for systemic sclerosis. IV. Assessment of skin thickening by modified Rodnan skin score. Ann Rheum Dis 2003; 62: 904-5.
    • (2003) Ann Rheum Dis , vol.62 , pp. 904-905
    • Valentini, G.1    D'angelo, S.2    Della Rossa, A.3    Bencivelli, W.4    Bombardieri, S.5
  • 41
    • 84934288965 scopus 로고    scopus 로고
    • B Cells in Autoimmune Diseases
    • HAMPE CS: B Cells in Autoimmune Diseases. Scientifica (Cairo) 2012; 2012: 1-18.
    • (2012) Scientifica (Cairo) , vol.2012 , pp. 1-18
    • Hampe, C.S.1
  • 42
    • 2942537697 scopus 로고    scopus 로고
    • Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis
    • EDWARDS JCW, SZCZEPANSKI L, SZECHINSKI J et al.: Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis. N Engl J Med 2004; 350: 2572-81.
    • (2004) N Engl J Med , vol.350 , pp. 2572-2581
    • Edwards, J.C.W.1    Szczepanski, L.2    Szechinski, J.3
  • 43
    • 84871031165 scopus 로고    scopus 로고
    • Human CD27+IgM+IgD+ B cells: T-cell or TLR-dependent?
    • Van ZELM MC: Human CD27+IgM+IgD+ B cells: T-cell or TLR-dependent? Blood 2012; 120: 4905-6.
    • (2012) Blood , vol.120 , pp. 4905-4906
    • Van Zelm, M.C.1
  • 44
    • 77952817885 scopus 로고    scopus 로고
    • Decreased frequency and activated phenotype of blood CD27 IgD IgM B lymphocytes is a permanent abnormality in systemic lupus erythematosus patients
    • RODRíGUEZ-BAYONA B, RAMOS-AMAYA A, PéREZ-VENEGAS JJ, RODRíGUEZ C, BRIEVA JA: Decreased frequency and activated phenotype of blood CD27 IgD IgM B lymphocytes is a permanent abnormality in systemic lupus erythematosus patients. Arthritis Res Ther 2010; 12: R108.
    • (2010) Arthritis Res Ther , vol.12 , pp. R108
    • Rodríguez-Bayona, B.1    Ramos-Amaya, A.2    Pérez-Venegas, J.J.3    Rodríguez, C.4    Brieva, J.A.5
  • 45
    • 34848912304 scopus 로고    scopus 로고
    • Delayed memory B cell recovery in peripheral blood and lymphoid tissue in systemic lupus erythematosus after B cell depletion therapy
    • ANOLIK JH, BARNARD J, OWEN T et al.: Delayed memory B cell recovery in peripheral blood and lymphoid tissue in systemic lupus erythematosus after B cell depletion therapy. Arthritis Rheum 2007; 56: 3044-56.
    • (2007) Arthritis Rheum , vol.56 , pp. 3044-3056
    • Anolik, J.H.1    Barnard, J.2    Owen, T.3
  • 46
    • 33748509736 scopus 로고    scopus 로고
    • A new memory CD27-IgG+ B cell population in peripheral blood expressing VH genes with low frequency of somatic mutation
    • FECTEAU JF, CôTé G, NéRON S: A new memory CD27-IgG+ B cell population in peripheral blood expressing VH genes with low frequency of somatic mutation. J Immunol 2006; 177: 3728-36.
    • (2006) J Immunol , vol.177 , pp. 3728-3736
    • Fecteau, J.F.1    Côté, G.2    Néron, S.3
  • 47
    • 0031754828 scopus 로고    scopus 로고
    • Mechanisms of CD95 (APO-1/Fas)-mediated apoptosis
    • PETER ME, KRAMMER PH: Mechanisms of CD95 (APO-1/Fas)-mediated apoptosis. Curr Opin Immunol 1998; 10: 545-51.
    • (1998) Curr Opin Immunol , vol.10 , pp. 545-551
    • Peter, M.E.1    Krammer, P.H.2
  • 48
    • 34247536682 scopus 로고    scopus 로고
    • The CD95 Receptor: Apoptosis Revisited
    • PETER ME, BUDD RC, DESBARATS J et al.: The CD95 Receptor: Apoptosis Revisited. Cell 2007; 129: 447-50.
    • (2007) Cell , vol.129 , pp. 447-450
    • Peter, M.E.1    Budd, R.C.2    Desbarats, J.3
  • 49
    • 5044228305 scopus 로고    scopus 로고
    • Fas ligation on macrophages enhances IL-1R1-Toll-like receptor 4 signaling and promotes chronic inflammation
    • MA Y, LIU H, TU-RAPP H et al.: Fas ligation on macrophages enhances IL-1R1-Toll-like receptor 4 signaling and promotes chronic inflammation. Nat Immunol 2004; 5: 380-7.
    • (2004) Nat Immunol , vol.5 , pp. 380-387
    • Ma, Y.1    Liu, H.2    Tu-Rapp, H.3
  • 50
    • 77953568668 scopus 로고    scopus 로고
    • Fas (CD95) induces rapid, TLR4/IRAK4-dependent release of proinflammatory HMGB1 from macrophages
    • WANG F, LU Z, HAWKES M, YANG H, KAIN KC, LILES WC: Fas (CD95) induces rapid, TLR4/IRAK4-dependent release of proinflammatory HMGB1 from macrophages. J Inflamm 2010; 7: 30.
    • (2010) J Inflamm , vol.7 , pp. 30
    • Wang, F.1    Lu, Z.2    Hawkes, M.3    Yang, H.4    Kain, K.C.5    Liles, W.C.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.